Wait...

Online Export Import Data Search

Recent Searches: No Recent Searches
Complete Training Video : Click Here

Spurious drugs imported from China raises red flag for pharma regulator.


Date: 12-11-2016
Subject: Spurious drugs imported from China raises red flag for pharma regulator
NEW DELHI: China is on the "radar" of the Indian government after a few instances of import of spurious and sub-standard drugs from the country were reported, said officials of a regulatory body for pharmaceuticals.

"Active pharmaceutical ingredient (API) estimated to be worth Rs 18,000 crore are imported in India annually and China is the main source of importing drugs in bulk. About 60 per cent of the API comes from China, while the rest comes from Italy, Japan, Europe and the USA.

"Also, it has come to notice that most of the cases of sub-standard drugs, drugs with dubious origin or suspected label are coming from China. To check such infiltration, we have put China on the radar," said an official of the Drug Controller General of India (DGCI) on condition of anonymity.

Clandestine operators push spurious pharmaceutical ingredients labelled under the name of authorised importers which compromise patients' safety, the official said, adding that during checks, it is often found that the drugs are not sourced from the Chinese manufacturers, whose names are referred to in the documents.

Notably, India imports medicines like antibiotics, anti-diabetic, anti-hypertensive, anti-cancer and other regular drugs from several countries and to keep a tab on such imports, the government has put in place an electronic platform -- ICEGATE -- to check their quality and authenticity.

Under this programme, the government has framed uniform procedures for sampling and inspection of the drug consignments that come from overseas.

"Through ICEGATE, consignments, bills of entry are electronically placed to the customs which are then scrutinised online by the DGCI port for quality and genuinity. The things which are checked for in imported drugs include documentation, quality, originality of labels etc," said the official.

Drug imports are only allowed from companies whose manufacturing units are registered with the Indian drug regulator.

However, at the domestic front, clandestine operators are much less because regular inspections and sampling of drugs are possible within the country.

DGCI in collaboration with state drug controllers have also launched risk-based inspections all across the country to check the quality of medicine and the manufacturing premises for GMP (Good Manufacturing Practice).

"200 units have been identified on the basis of risks and 105 of them have been inspected. None of them were found to be 100 per cent compliant," the official said.

Source : economictimes.indiatimes.com

Get Sample Now

Which service(s) are you interested in?
 Export Data
 Import Data
 Both
 Buyers
 Suppliers
 Both
OR
 Exim Help
+


What is New?

Date: 27-11-2020
Notification No. 109/2020-CUSTOMS (N.T.)
Tariff Notification in respect of Fixation of Tariff Value of Edible Oils, Brass Scrap, Poppy Seeds, Areca Nut, Gold and Silver- Reg

Date: 27-11-2020
Circular No. 52/2020-Customs
Exports of Gems and Jewellery through Courier mode - reg.

Date: 27-11-2020
Notification No. 40/2020-Customs (ADD)
Seeks to impose Anti-Dumping duty on Fluoroelastomers (FKM) originating in or exported from China PR for a period of 5 years, in pursuance of sunset review final findings issued by DGTR

Date: 26-11-2020
Notification No. 43/2020-Customs
Seeks to further amend notification No. 50/2017-Customs dated 30th June, 2017 so as to prescribe BCD rate of 27.5% on Crude Palm Oil

Date: 26-11-2020
Notification No. 39/2020-Customs (ADD)
Seeks to amend notification No. 51/2015-Customs (ADD), dated 21st October, 2015 to extend the levy of ADD on imports of "Fully Drawn or Fully Oriented Yarn/Spin Drawn Yarn/Flat Yarn of Polyester " originating in or exported from China PR & Thailand , for a further period upto and inclusive of 31st December, 2020

Date: 26-11-2020
Public Notice No. 30/2015-20
Revision of SION A1827 of Export Products - Ossein

Date: 23-11-2020
A.P. (DIR Series) Circular No. 07
Establishment of Branch Office (BO) / Liaison Office (LO) / Project Office (PO) or any other place of business in India by foreign law firms

Date: 20-11-2020
Circular No.51/2020-Customs
Clarifications regarding availment of exemption on temporary import of durable Containers - reg.

Date: 19-11-2020
Notification No. 60/2020-Customs (N.T./CAA/DRI)
Appointment of CAA by Pr. DGRI

Date: 19-11-2020
Notification No. 61/2020-Customs (N.T./CAA/DRI)
Appointment of CAA by Pr. DGRI



Exim Guru Copyright © 1999-2020 Exim Guru. All Rights Reserved.
The information presented on the site is believed to be accurate. However, InfodriveIndia takes no legal responsibilities for the validity of the information.
Please read our Terms of Use and Privacy Policy before you use this Export Import Data Directory.

EximGuru.com

C/o InfodriveIndia Pvt Ltd
F-19, Pocket F, Okhla Phase-I
Okhla Industrial Area
New Delhi - 110020, India
Phone : 011 - 40703001